Creating a Better Pathologist
Cart 0

2020, October 19-20: A Contemporary Approach and Update on the Classification, Grading, Staging and Reporting of GU Tumors

$799.00

Oct. 19-20, 2020 - Palm Springs, California

Available Credits 15 CME / 15 SAMs

Schedule | Faculty | Social Distancing Guidelines

COURSE DESCRIPTION

Classification, grading, staging and reporting of GU tumors continue to evolve with the discovery of pathogenic mechanisms and the advent of novel diagnostic tools and therapies. It is imperative for practicing pathologists to keep pace with the important changes in GU tumor pathology in order to produce pathology diagnoses and reports that meet contemporary patient management needs. Examples requiring educational focus are the significant error rate and inter-observer variability in the diagnosis of cribriform carcinoma and intraductal carcinoma of prostate; under-recognition and under-reporting of bladder cancer variants; misclassification of testicular germ cell tumors correlated with drastic revision of WHO 2016 classification; modifications in prostate grading correlative with newly described morphologic changes, new outcome data and adjustment to the modified Gleason grading system; changes in GU tumor staging following publication of the 8th edition of the AJCC Staging guidelines; requisite refinements in cancer reporting to eliminate significant variation, error, and missing relevant elements. This course is a pragmatic exercise in mentoring for advanced learning taught by international experts who reflect USCAP’s gold standard.

COURSE OBJECTIVES 

  • Recognize, correctly diagnose and classify new GU tumor types
  • Correctly apply new and modified grading criteria for GU cancers
  • Correctly apply new and modified staging criteria for GU cancers
  • Learn new concepts and reporting requirements for GU tumors

COURSE DIRECTOR

  • Ming Zhou, MD, PhD
    Tufts Medical Center/Tufts University School of Medicine

FACULTY

  • Elizabeth M. Genega, MD
    Tufts Medical Center/Tufts University School of Medicine
  • Cristina Magi-Galluzzi, MD, PhD
    University of Alabama at Birmingham
  • Sean R. Williamson, MD
    Henry Ford Health System/Wayne State University School of Medicine

CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION 

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC).

Physicians can earn a maximum of 15 SAM/Part II credit hours.

PHOTO POLICY

USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.

CANCELLATION POLICY

In the context of the pandemic crisis, USCAP is indefinitely suspending its cancellation policy on all scheduled and upcoming courses until there is a resolution or return to normalcy. However, we encourage you to register (without penalty) for advertised courses (months ahead) in anticipation of return to face-to-face conferences. You can secure your position in advance and cancel, if necessary, with full refund.



More from this collection